BACKGROUND: Several lines of evidence suggest that male embryos may have greater vulnerability than female embryos to disordered inflammation; therefore, antiinflammatory drugs, such as low-dose aspirin (LDA), may alter the sex ratio. Here, we assessed the effect of LDA on male live birth and male offspring, incorporating pregnancy losses (n = 56) via genetic assessment, as part of a parallel-design, block-randomized, placebo-controlled trial of preconception LDA. METHODS:Participants (615 treated with LDA, 613 treated with placebo) ranged in age from 18 to 40 years of age, with 1 to 2 prior pregnancy losses. We estimated the intention-to-treat (ITT) risk ratio (RR) and 95% CI and assessed interaction with baseline high-sensitivity C-reactive protein (hsCRP) serum concentration - a marker of systemic inflammation. RESULTS: Among the 1,078 women who completed follow-up (535 treated with LDA, 543 treated withplacebo), the male live birth ITT RR equaled 1.31 (95% CI: 1.07-1.59). With increasing tertile of hsCRP, the proportion of males at birth decreased in the placebo group, and the effect of LDA on male live birth increased (first tertile: 48% male in LDA vs. 52% in placebo, ITT RR = 0.97, 95% CI: 0.70-1.35; second tertile: 57% male in LDA vs. 43% in placebo, ITT RR = 1.36, 95% CI: 0.98-1.90; third tertile: 53% male in LDA vs. 35% in placebo, ITT RR = 1.70, 95% CI: 1.13-2.57; P interaction = 0.03). Analysis of pregnancy with male offspring yielded similar results. CONCLUSION: Initiation of LDA prior to conception restored numbers of male live births and pregnancy with male offspring among women with 1 to 2 prior pregnancy losses. Moreover, our data suggest that LDA modulates inflammation that would otherwise reduce the conception or survival of male embryos. TRIAL REGISTRATION: ClinicalTrials.gov NCT00467363. FUNDING: Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.
RCT Entities:
BACKGROUND: Several lines of evidence suggest that male embryos may have greater vulnerability than female embryos to disordered inflammation; therefore, antiinflammatory drugs, such as low-dose aspirin (LDA), may alter the sex ratio. Here, we assessed the effect of LDA on male live birth and male offspring, incorporating pregnancy losses (n = 56) via genetic assessment, as part of a parallel-design, block-randomized, placebo-controlled trial of preconception LDA. METHODS:Participants (615 treated with LDA, 613 treated with placebo) ranged in age from 18 to 40 years of age, with 1 to 2 prior pregnancy losses. We estimated the intention-to-treat (ITT) risk ratio (RR) and 95% CI and assessed interaction with baseline high-sensitivity C-reactive protein (hsCRP) serum concentration - a marker of systemic inflammation. RESULTS: Among the 1,078 women who completed follow-up (535 treated with LDA, 543 treated with placebo), the male live birth ITT RR equaled 1.31 (95% CI: 1.07-1.59). With increasing tertile of hsCRP, the proportion of males at birth decreased in the placebo group, and the effect of LDA on male live birth increased (first tertile: 48% male in LDA vs. 52% in placebo, ITT RR = 0.97, 95% CI: 0.70-1.35; second tertile: 57% male in LDA vs. 43% in placebo, ITT RR = 1.36, 95% CI: 0.98-1.90; third tertile: 53% male in LDA vs. 35% in placebo, ITT RR = 1.70, 95% CI: 1.13-2.57; P interaction = 0.03). Analysis of pregnancy with male offspring yielded similar results. CONCLUSION: Initiation of LDA prior to conception restored numbers of male live births and pregnancy with male offspring among women with 1 to 2 prior pregnancy losses. Moreover, our data suggest that LDA modulates inflammation that would otherwise reduce the conception or survival of male embryos. TRIAL REGISTRATION: ClinicalTrials.gov NCT00467363. FUNDING: Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health.
Authors: Enrique F Schisterman; Robert M Silver; Neil J Perkins; Sunni L Mumford; Brian W Whitcomb; Joseph B Stanford; Laurie L Lesher; David Faraggi; Jean Wactawski-Wende; Richard W Browne; Janet M Townsend; Mark White; Anne M Lynch; Noya Galai Journal: Paediatr Perinat Epidemiol Date: 2013-10-11 Impact factor: 3.980
Authors: M Pérez-Crespo; M A Ramírez; R Fernández-González; D Rizos; P Lonergan; B Pintado; A Gutiérrez-Adán Journal: Mol Reprod Dev Date: 2005-12 Impact factor: 2.609
Authors: Jan J Brosens; Madhuri S Salker; Gijs Teklenburg; Jaya Nautiyal; Scarlett Salter; Emma S Lucas; Jennifer H Steel; Mark Christian; Yi-Wah Chan; Carolien M Boomsma; Jonathan D Moore; Geraldine M Hartshorne; Sandra Sućurović; Biserka Mulac-Jericevic; Cobi J Heijnen; Siobhan Quenby; Marian J Groot Koerkamp; Frank C P Holstege; Anatoly Shmygol; Nick S Macklon Journal: Sci Rep Date: 2014-02-06 Impact factor: 4.379
Authors: Lindsay D Levine; Tiffany L Holland; Keewan Kim; Lindsey A Sjaarda; Sunni L Mumford; Enrique F Schisterman Journal: Can J Physiol Pharmacol Date: 2018-12-18 Impact factor: 2.273
Authors: Matthew T Connell; Lindsey A Sjaarda; Rose G Radin; Daniel Kuhr; Sunni L Mumford; Torie C Plowden; Robert M Silver; Enrique F Schisterman Journal: Semin Reprod Med Date: 2017-10-16 Impact factor: 1.303
Authors: Alexandra C Purdue-Smithe; Keewan Kim; Carrie Nobles; Enrique F Schisterman; Karen C Schliep; Neil J Perkins; Lindsey A Sjaarda; Joshua R Freeman; Sonia L Robinson; Jeannie G Radoc; James L Mills; Robert M Silver; Aijun Ye; Sunni L Mumford Journal: Nat Commun Date: 2021-05-13 Impact factor: 14.919
Authors: Lindsey A Sjaarda; Rose G Radin; Robert M Silver; Emily Mitchell; Sunni L Mumford; Brian Wilcox; Noya Galai; Neil J Perkins; Jean Wactawski-Wende; Joseph B Stanford; Enrique F Schisterman Journal: J Clin Endocrinol Metab Date: 2017-05-01 Impact factor: 5.958
Authors: Satu Wedenoja; Masahito Yoshihara; Hindrek Teder; Hannu Sariola; Mika Gissler; Shintaro Katayama; Juho Wedenoja; Inka M Häkkinen; Sini Ezer; Nina Linder; Johan Lundin; Tiina Skoog; Ellika Sahlin; Erik Iwarsson; Karin Pettersson; Eero Kajantie; Mikael Mokkonen; Seppo Heinonen; Hannele Laivuori; Kaarel Krjutškov; Juha Kere Journal: EBioMedicine Date: 2020-07-14 Impact factor: 8.143